BNET Industries

Last Fiscal Year Sales:$1.2M
  • Public
  • US
Dow Jones Description

During the past two years, we have refocused our efforts on the development of medical imaging agents, including cardiovascular and lymphography contrast imaging agents. We accomplished this shift in focus by splitting off our therapeutic line of business, as more fully described in ?Recent Developments? below. We are currently an emerging, development-stage biopharmaceutical company focused on developing a novel contrast agent with potential applications (1) as a blood pool agent, to diagnose diseased tissue in the cardiovascular system and other organs, and (2) to diagnose cancer metastasizing into the lymphatic system. We are the exclusive licensee of a group of proprietary materials, the lead compound of which is a contrast agent we refer to as PH-50 or N1177. We established the two names to distinguish commercialization rights between cardiovascular imaging (and all other indications) (PH-50) to which we retain rights, and the field of lymphography (N1177), which we licensed to our joint venture (Sentigen, Ltd.) with affiliates of Elan Corporation, plc (?Elan?).

Director, Chairman
Lester H McKeever Jr
Contact Information

6175 Lusk Boulevard

San Diego, California 92121

858 410-5601

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

imcor pharmaceutical co. - All News and Analysis

Decision Makers

Name (plus bio) Position
Alan Watson Director
Robert J Weinstein Director

Board of Directors

Name (plus bio) Position
Lester H McKeever Jr Director, Chairman
Jonathan Fleming Board of Directors

Organization Position Status
Imcor Pharmaceutical Co Director, Chairman Current

Organization Position Status
Centagenetix, Inc. Executive Vice President and Chief Business Officer Current
Targeted Diagnostics & Therapeutics, Inc. Executive Vice President, Chief Business Officer Current
Smartcells Inc Vice President of Business Development Current
Optimum Percussion Managing Director Current
Imcor Pharmaceutical Co Director Current
Elixir Pharmaceuticals, Inc. Chief Business Officer Former
Elixir Pharmaceuticals, Inc. Executive Vice President Former
Northeastern University Ph.D. In Bioinorganic Chemistry Former
National University Ph.D. In Bioinorganic Chemistry Former
Northeastern University M.B.A. Former
University of NSW B.Sc. Former
University Corp. B.Sc. Former

Jonathan J. Fleming is one of our co-founders and is Chairman of our Board of Directors. Mr. Fleming served as Chairman from January 1998 to May 2005 and assumed the position again in October 2006. Mr. Fleming has served as the Managing Partner of Oxford Bioscience Partners, a venture capital firm specializing in life science technology since 1996. Prior to joining Oxford Bioscience, he served as a Founding Partner of MVP Ventures in Boston, Massachusetts. Mr. Fleming serves as a member of the board of directors of Imcor Pharmaceutical Co. (formerly Photogen Technologies, Inc.), a specialty pharmaceutical company focused on developing medical imaging pharmaceutical products. He also serves as Chairman of the board of directors of BioProcessors Corporation, a privately-held corporation, and as a director of seven other privately-held companies, including Leerink Swann & Company, Inc., a Boston-based investment bank specializing in health care companies. Mr. Fleming is a Trustee of the Museum of Science in Boston and is a Senior Lecturer at Massachusetts Institute of Technology's Sloan School of Management. Mr. Fleming received a B.A. from the University of California, Berkeley and a Masters in Public Administration from Princeton University.

Organization Position Status
Memory Pharmaceuticals Corp. Co-Founder Current
Oxford Bioscience Partners Managing Partner Current
MIT Sloan School of Management Senior Lecturer Current
Leerink Swann & Company Managing Partner of Oxford Bioscience Partners Current
Massachusetts Life Sciences Collaborative Managing General Partner, Oxford Bioscience Partners Current
Hypnion, Inc. Current
Centagenetix, Inc. Current
The Convergence Forum Current
BioProcessors Corp. Chairman Current
Braincells, Inc. Board of Directors Current
Memory Pharmaceuticals Corp. Chairman of the Board Current
Railrunner Board of Directors Current
Asterand, Plc. Board of Directors Current
Museum of Science Board of Directors Current
Elixir Pharmaceuticals, Inc. Board of Directors Current
Nehi Board of Directors Current
Alta Partners Director Current
Synaptic Pharmaceutical Corp Director Current
Leerink Swann & Company Board of Directors Current
Museum of Science Trustee Current
Medica Venture Partners Co-Founder Former
MVP Ventures Founding General Partner Former
Medica Venture Partners Special Limited Partner Former
Tvm Techno Venture Management General Partner Former
Oxford Bioscience Partners Owner Former
Biotechnology Venture Investors Group Chairman Former
Princeton University Master's Degree In Public Administration Former
University of California, Berkeley Master's Degree In Public Administration Former
University of California, Berkeley Bachelor of Arts Degree Former
University of California B.A. Former

Organization Position Status
Imcor Pharmaceutical Co Director Current
advertisement
advertisement